Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AX Various alimentary tract and metabolism products
A16AX04 Nitisinone
D05177 Nitisinone (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Nitisinone
D05177 Nitisinone (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D05177 Nitisinone (JAN/USAN/INN)
Drug groups [BR:br08330]
Metabolizing enzyme inhibitor
DG01643 CYP2C9 inhibitor
D05177 Nitisinone
Transporter inhibitor
DG02901 SLC22A6 inhibitor
D05177 Nitisinone
DG02866 SLC22A8 inhibitor
D05177 Nitisinone
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dioxygenases
HPD
D05177 Nitisinone (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D05177
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D05177
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D05177
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D05177
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D05177
Drug transporters
D05177
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D05177